Cancer


The Cancer Documentary addresses the worldwide cancer epidemic head-on, exploring an aspect of cancer that is often overlooked, its connection with diet and lifestyle.
#health #cancer #documentary #fullmovie #wellness #diet #healthyeating #healthyfood
Directed by: Jerome Heaven
Starring: Warren Brown, Veronique Desaulniers, Michael Gregor
WANT TO SEE MORE MOVIES LIKE THIS FOR FREE here on YouTube?
Just visit our other channel for hundreds of free movies and documentaries!
https://youtube.com/@gravitasventuresVOD | https://youtube.com/@gravitasadrenaline | https://youtube.com/@gravitasunexplained


#cartcelltherapy #beijing #cancertreatment
You can learn more about car t cell therapy in China you can check out: https://cancerfax.com/car-t-cell-therapy-in-china
Patient visited Beijing Hospital in, China.
The video is all about CAR T-cell therapy treatment in China but also try to cover the following subject:
-CAR T-cell therapy
-What is car t-cell therapy?
-Top hospitals for CAR T-Cell therapy in China
So you wish to know more about car t cell therapy, I did too and here's the outcome.
Car t cell therapy intrigued me so I did some research and uploaded this to YouTube .
~~~~~~~~~~~~~~~~~~~~~
Our YouTube channel has other similar videos about car t-cell therapy, what is car t-cell therapy and CAR T-Cell therapy in China
Please check them out : https://www.youtube.com/@cancerfax
If you were looking for more details about car t-cell therapy or what is car t-cell therapy did this video assistance?
Possibly you would like to comment below and let me know what else I can assist you with or information on car t cell therapy.
Services provided by CancerFax to cancer patients:
1) Cancer treatment in leading hospitals
2) Cancer clinical trials recruitment
3) CAR T Cell therapy
4) Proton therapy
5) Cancer vaccine
Empowering Lives, Transforming Journeys:
Our vision is to lead the way in revolutionizing cancer treatment facilitation, ensuring every individual's access to personalized, comprehensive, and compassionate care. Through innovative solutions and unwavering dedication, we strive to eliminate barriers, provide hope, and contribute to a world where cancer is not just treatable, but conquerable.
To know more about what we do, please visit: https://cancerfax.com/
At CancerFax, our mission is to be the bridge between individuals battling cancer and the advanced treatments they deserve. We are committed to:
Personalized Pathways: Tailoring #treatment options to each patient's unique needs, #medical history, and preferences, guaranteeing a journey centered on holistic well-being.
Global Network: Building a global network of renowned #oncologists, cutting-edge treatment centers, and support services, ensuring access to the finest expertise and facilities, regardless of geographic location.
Empowerment Through Knowledge: Providing comprehensive, up-to-date information about treatment choices, potential outcomes, and supportive resources, empowering patients to make informed decisions.
Compassionate Support: Offering emotional and practical support throughout the cancer journey, fostering a community of strength, understanding, and empathy for patients and their loved ones.
Innovation and Research: Collaborating with leading research institutions to stay at the forefront of advancements, pioneering new approaches that continually enhance the efficacy and quality of cancer treatment.
Advocacy and Awareness: Advocating for improved cancer care policies, reducing stigmas, and increasing public awareness, contributing to a world that is proactive in the fight against cancer.
Ethical Excellence: Upholding the highest ethical standards in all our interactions, ensuring transparency, fairness, and respect for the dignity of every individual we serve.
Through unwavering commitment, innovation, and a compassionate spirit, we aspire to redefine the cancer treatment landscape, offering hope, healing, and a brighter future for all those touched by cancer.
Follow our videos concerning #cancertreatment and various other similar topics on:
Facebook: https://www.facebook.com/cancerfax
Twitter: https://twitter.com/cancerfax
Instagram: https://instagram.com/cancerfax
YouTube: https://youtube.com/@cancerfax

Madrid, 21 may (efesalud.com). El doctor Jorge Adeva Alfonso vídeobloguea desde el laboratorio oncológico del Hospital 12 de Octubre acerca de los dos tipos cáncer de esófago más prevalentes en la sociedad, los tumores que prosperan después de la garganta, gracias al hábito tabáquico o al exceso de alcohol, y las neoplasias ocasionadas por el reflujo gástrico en la zona más distal del esófago o boca de entrada al estómago. <br /> <br />Mientras los primeros, que se denominan escamosos, han tendido a disminuir su incidencia en la población durante los últimos años, los segundos, que forman el llamado esófago de Barrett, se han convertido en "casi una epidemia" en las dos últimas décadas. <br /> <br />Las primeras señales que indican que podemos padecer un carcinoma esofágico aparecen cuando tenemos dificultades para tragar, estamos experimentando dolor torácico, perdemos peso o no se nos abre el apetito; síntomas por los que debemos acudir sin pausa al médico de cabecera o al especialista de aparato digestivo. <br /> <br />Para diagnosticar un cáncer de esófago se recurre a la gastroscopia: una vez sedado el paciente, se introduce una sonda por su nariz hasta que se llega a la zona de exploración, donde se efectuará una biopsia. La muestra extraída se enviará al anatomopatólogo. <br /> <br />En ocasiones, el endoscopista puede hacer también una ecoendoscopia aprovechando la gastroscopia. El galeno observa la zona tumoral con el ecógrafo y estudia el carcinoma in situ. <br /> <br />"Evaluado ya el cáncer de esófago, si está muy localizado y delimitado, se puede hacer un tratamiento curativo a través de la propia endoscopia, resecando el tumor sin necesidad de operar. Esto solo se debe hacer en centros de alta experiencia como el Hospital 12 de Octubre", informa el doctor Jorge Adeva. <br /> <br />Cuando el desarrollo del tumor todavía está en una fase primaria, se puede individualizar al paciente: "O bien se lleva a cabo una cirugía mayor o bien se le trata con radioterapia o quimioterapia para evitar la cirugía", explica. <br /> <br />Si el cáncer se ha diseminado y se ha pasado a otros órganos del cuerpo humano, metátasis, se ofrece un tratamiento paliativo que mejore su calidad de vida y expectativa de supervivencia. <br /> <br />"Desde hace un quinquenio, además de las terapias clásicas de radioterapia y quimioterapia, se administra la proteína HER2 a un grupo determinado de pacientes con cáncer de esófago", detalla Adeva. <br /> <br />La proteína HER2 es clave en el crecimiento y división de las células, por lo que se ha convertido en una diana de los tratamientos oncogénicos. <br /> <br />"Como ya sucediera en grupos de pacientes con cáncer de mama, la efectividad es mayor si a la proteína se añaden el tratamiento con quimioterapia clásica y un fármaco que se llama trastuzumab", asegura. <br /> <br />Y todo gracias a los voluntarios que participan en los ensayos clínicos para encontrar y probar nuevas terapias. <br /> <br />"En este caso, la suerte se alió con la investigación. En el laboratorio del Hospital 12 de Octubre buscamos nuevas dianas para atacar los procesos cancerígenos -refrenda. Somos muy optimistas porque los oncólogos trabajamos con gran pasión para intentar mejorar la calidad de vida y las expectativas de supervivencia de nuestros pacientes". <br /> <br />Para Jorge Adeva Alfonso, en cualquier caso, y con la bienvenida gratificante a los avances farmacológicos, no se puede bajar la guardia contra el cáncer, sobre todo en la prevención. <br /> <br />"La población debe alimentarse mejor, dejar de fumar y beber con moderación", concluye. <br /> <br />Todos los vídeoblogs sobre cáncer: http://goo.gl/5bfWbp <br /> <br />Más vídeos y reportajes en http://www.efesalud.com/

Intervista al prof. Giampiero Girolomoni, Professore ordinario di Dermatologia e Direttore della Clinica Dermatologica dell’Università degli studi di Verona. <br />Una cura innovativa per il trattamento dei tumori cutanei, un ciclo di terapia di due o tre giorni con un’unica somministrazione topica quotidiana, per trattare rapidamente le lesioni da cheratosi attinica, malattia della cute di cui soffrono milioni di persone in Italia e nel mondo. <br /> <br /> <br /> <br />Arriva in Italia Picato®, gel a base di ingenolo mebutato, frutto dell’impegno di LEO Pharma, azienda farmaceutica danese leader in Dermatologia. <br /> <br />La cheratosi attinica, patologia cutanea la cui prevalenza è in costante aumento e con un’incidenza variabile a seconda della presenza di uno o più fattori di rischio (esposizione prolungata al sole, storia di ustioni solari, fototipo chiaro, segni di danno solare, pregressi tumori cutanei) è ancora poco conosciuta e sotto-diagnosticata nonostante le lesioni possano progredire nel più frequente tumore della pelle non-melanoma, ovvero il carcinoma squamocellulare invasivo (SCC). La sua prevalenza varia tra l’11 e il 25% e arriva fino al 60%, negli adulti sopra i 40 anni nella popolazione dell’emisfero sud (Stockfleth et al., EJD 2008). In Italia è stimata attorno all’1,4% dopo i 45 anni (Naldi et al., Arch. Dermatol. 2006). <br /> <br />Chi è affetto da cheratosi attinica ha una probabilità 10 volte maggiore di sviluppare un tumore della pelle nei 12 mesi successivi se paragonato al resto della popolazione (Wolf et al., Int. J. Dermatol. 2013); i pazienti oltre i 65 anni hanno un rischio 6 volte superiore di sviluppare un carcinoma cutaneo rispetto a chi non è affetto da cheratosi attinica (Traianou et al., BJD 2012). La principale causa di cheratosi attinica è la radiazione UVB dei raggi solari che induce una mutazione specifica del DNA cellulare. <br /> <br />«La cheratosi attinica è una forma di carcinoma allo stadio iniziale o “in situ”; le lesioni attiniche sono molto antiestetiche e ciascuna potenzialmente pericolosa perché a rischio di evoluzione maligna», afferma Giampiero Girolomoni, Professore ordinario di Dermatologia e Direttore della Clinica Dermatologica dell’Università degli studi di Verona. «Non è possibile prevedere quale e quando una delle numerose lesioni andrà incontro a una progressione in carcinoma squamoso cellulare, tumore maligno che richiede una diagnosi precoce e un trattamento adeguato di tutte le lesioni». <br /> <br />http://www.salutedomani.com/il...._weblog_di_antonio/2

For more info on this and other stories, visit www.newsinfusion.com Denver, CO - Lauren Miller is a survivor, in every sense of the word. On January 10, 2006, two weeks prior to her final divorce court date, the mother of three children, second degree black belt, fitness trainer, inspirational speaker and teacher, was diagnosed with stage three breast cancer: invasive ductal carcinoma grade three. She was given a 50 percent chance of survival because of her age and the advanced stage of her cancer. In her first book Hearing His Whisper, Lauren Miller shares her remarkable story of hope and perseverance in the midst of cancer and divorce. “I tell people it’s not about what you do in life, but about who you are in relation to God and others,” says Miller. “You can’t always help what happens in life when it comes to life and death, but you can choose how to respond to your circumstances.”

http://leukemiabloodcancer.blogspot.com/ Visit my blog to get valuable information regarding leukemia / blood cancer. The latest research findings, and more. blood cancer, leukemia, leukemia symptoms, symptoms leukemia, lymphocytic leukemia, myeloid leukemia